Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

OPK

Opko Health Inc

Apr 24 • 04:00PM ET

1.23

Dollar change -0.02
Percentage change -1.60	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IWM VB VTI VXF IWN IBB VBR FNDA SCHA VBK

Index	RUT	P/E	-	EPS (ttm)	-0.25	Insider Own	52.98%	Shs Outstand	773.28M	Perf Week	-1.60%
Market Cap	857.30M	Forward P/E	-	EPS next Y	-0.26	Insider Trans	3.16%	Shs Float	327.73M	Perf Month	21.78%
Income	-188.89M	PEG	-	EPS next Q	-0.10	Inst Own	27.31%	Short Float	28.56%	Perf Quarter	23.12%
Sales	863.49M	P/S	0.99	EPS this Y	-46.29%	Inst Trans	-3.05%	Short Ratio	10.17	Perf Half Y	-2.38%
Book/sh	1.80	P/B	0.68	EPS next Y	29.96%	ROA	-9.04%	Short Interest	93.61M	Perf Year	-15.75%
Cash/sh	0.14	P/C	8.94	EPS next 5Y	12.00%	ROE	-12.80%	52W Range	0.85 - 2.24	Perf YTD	-18.54%
Dividend Est.	-	P/FCF	-	EPS past 5Y	1.56%	ROI	-11.29%	52W High	-45.09%	Beta	1.81
Dividend TTM	-	Quick Ratio	1.22	Sales past 5Y	3.29%	Gross Margin	26.88%	52W Low	44.43%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	1.55	EPS Y/Y TTM	44.76%	Oper. Margin	-18.31%	RSI (14)	54.96	Volatility	4.15% 6.19%
Employees	3930	Debt/Eq	0.24	Sales Y/Y TTM	-14.02%	Profit Margin	-21.87%	Recom	1.00	Target Price	4.25
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	22.10%	Payout	-	Rel Volume	0.66	Prev Close	1.25
Sales Surprise	2.46%	EPS Surprise	10.00%	Sales Q/Q	-1.89%	Earnings	Feb 27 AMC	Avg Volume	9.20M	Price	1.23
SMA20	-2.36%	SMA50	13.56%	SMA200	-12.28%	Trades		Volume	6,062,915	Change	-1.60%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-29-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$2
Dec-15-22	Initiated	H.C. Wainwright	Buy	$3
Jan-24-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Jun-21-21	Initiated	Ladenburg Thalmann	Buy	$7
Nov-25-19	Initiated	Piper Jaffray	Overweight	$2.50
Mar-02-18	Downgrade	JP Morgan	Neutral → Underweight
Sep-14-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-21-16	Reiterated	Standpoint Research	Buy	$16 → $18
Jun-03-16	Initiated	Standpoint Research	Buy	$16
Mar-31-16	Reiterated	Barrington Research	Outperform	$17 → $16
Oct-16-15	Initiated	JP Morgan	Overweight	$14
Sep-11-15	Downgrade	Jefferies	Buy → Hold
Mar-03-15	Downgrade	Oppenheimer	Outperform → Perform
May-12-14	Reiterated	Oppenheimer	Outperform	$13 → $12
Mar-14-14	Initiated	Oppenheimer	Outperform	$13
Nov-13-13	Reiterated	Ladenburg Thalmann	Buy	$10 → $14.50
May-30-13	Reiterated	Ladenburg Thalmann	Buy	$8.50 → $10
Oct-22-12	Initiated	Barrington Research	Outperform	$6
Dec-01-11	Reiterated	Ladenburg Thalmann	Buy	$6 → $8.50
Jul-14-11	Initiated	Ladenburg Thalmann	Buy	$6

Show Previous Ratings

Apr-01-24 01:01PM	OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp (Zacks) +9.17%
Mar-28-24 11:08PM	Labcorp inks $237.5M buyout of Opkos reproductive, womens health testing assets (MedTech Dive) +12.15%
08:00AM	Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business (PR Newswire)
Mar-25-24 09:57AM	OPKO Health (OPK) And Entera Bio Announce Data for GLP-2 (Zacks)
Mar-20-24 08:00AM	Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome (GlobeNewswire)
08:52AM	Loading…
Mar-05-24 08:52AM	AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV (GlobeNewswire) -6.51%
Feb-29-24 08:31AM	OPKO Health, Inc. (NASDAQ:OPK) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 09:31AM	NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st (PR Newswire) -6.14%
09:02AM	OPKO Health's (OPK) Q4 Earnings Match Estimates, Revenues Top (Zacks)
06:18AM	Q4 2023 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-24 09:00PM	Opko Health (OPK) Q4 2023 Earnings Call Transcript (Motley Fool) +5.37%
07:30PM	OPKO Health (OPK) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
06:10PM	OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:08PM	OPKO Health: Q4 Earnings Snapshot (Associated Press Finance)
04:43PM	OPKO Health Inc (OPK) Reports Fourth Quarter 2023 Results (GuruFocus.com)
04:05PM	Loading…
04:05PM	OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results (GlobeNewswire)
Feb-26-24 09:16AM	Gear Up for OPKO Health (OPK) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks) +5.34%
Feb-22-24 04:05PM	OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 (GlobeNewswire)
Feb-08-24 01:48PM	Hedge Fund and Insider Trading News: Adam Schwartz, Bill Ackman, Eisler Capital, Brevan Howard Asset Management, Balyasny Asset Management, Citadel LLC, OPKO Health, Inc. (OPK), and More (Insider Monkey)
Feb-05-24 08:09AM	NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China (PR Newswire)
Jan-22-24 11:48AM	3 Stocks with Major Insider Buying This Month (InvestorPlace)
Jan-09-24 04:05PM	OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes (GlobeNewswire)
Jan-08-24 08:00AM	OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +12.54%
Jan-04-24 11:31PM	OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 (GlobeNewswire) -39.55%
Jan-03-24 05:05PM	OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029 (GlobeNewswire)
Dec-07-23 10:20AM	Here's Why You Should Retain OPKO Health (OPK) Stock for Now (Zacks)
Dec-06-23 11:30AM	Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report? (Zacks)
Nov-28-23 07:00AM	BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing (PR Newswire)
Nov-07-23 10:36AM	Q3 2023 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
10:29AM	OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top (Zacks)
09:19AM	Loading…
09:19AM	OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript (Insider Monkey)
06:45AM	BioReference Signs On as the First Laboratory to Use MSK-ACCESS Powered with SOPHiA DDM (PR Newswire)
01:00AM	Opko Health (OPK) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-06-23 07:30PM	OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:30PM	OPKO Health: Q3 Earnings Snapshot (Associated Press Finance)
05:01PM	OPKO Health Inc (OPK) Reports Third Quarter 2023 Financial Results (GuruFocus.com)
04:05PM	OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results (GlobeNewswire)
Nov-02-23 10:00AM	New Clinical Data on OPKO Health's RAYALDEE (ER Calcifediol) Presented at Kidney Week 2023 (GlobeNewswire)
Oct-31-23 08:00AM	OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023 (GlobeNewswire)
Oct-25-23 04:25PM	OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023 (GlobeNewswire)
Oct-12-23 10:50AM	NextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global (ACCESSWIRE)
Oct-06-23 12:03PM	OPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats (Zacks)
Sep-29-23 01:03PM	OPKO Health Inc (OPK): A Deep Dive into Its Performance Potential (GuruFocus.com) +6.67%
Sep-28-23 07:36PM	OPKO Health (OPK) - A Fairly Valued Stock with Room for Growth? (GuruFocus.com)
04:08PM	ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats (GlobeNewswire)
Sep-13-23 01:18PM	OPKO Health (OPK) Ties Up for Oral Peptide Tablet Formulations (Zacks)
Sep-12-23 08:30AM	Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes (GlobeNewswire)
Aug-28-23 11:56AM	Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio (Zacks)
Aug-07-23 01:21PM	OPKO Health (OPK) Q2 Earnings and Revenues Top Estimates (Zacks) -8.54%
Aug-04-23 01:00AM	Opko Health (OPK) Q2 2023 Earnings Call Transcript (Motley Fool) +7.57%
Aug-03-23 05:55PM	OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +5.11%
04:48PM	OPKO Health: Q2 Earnings Snapshot (AP Finance)
04:05PM	OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results (GlobeNewswire)
Jul-25-23 04:05PM	OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023 (GlobeNewswire)
Jul-23-23 08:11AM	OPKO Health (NASDAQ:OPK) investors are sitting on a loss of 61% if they invested three years ago (Simply Wall St.)
Jul-12-23 08:25AM	Strength Seen in Tandem Diabetes Care, Inc. (TNDM): Can Its 8.9% Jump Turn into More Strength? (Zacks)
Jun-29-23 03:51PM	Why Shares of Opko Health Jumped on Thursday (Motley Fool) +13.66%
11:23AM	OPKO Health's (OPK) NGENLA Approved by FDA for GHD Treatment (Zacks)
09:53AM	Disney downgraded, Micron upgraded: Wall Street's top analyst calls (The Fly)
08:10AM	Pfizer (PFE) Gets FDA Nod for Growth Hormone Deficiency Drug (Zacks)
Jun-28-23 07:03AM	UPDATE 3-Pfizer-OPKO's growth hormone drug gets US approval in kids (Reuters)
06:51AM	US FDA approves Pfizer's drug for growth hormone deficiency (Reuters)
06:45AM	FDA Approves Pfizers NGENLA, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency (Business Wire)
Jun-08-23 07:11AM	Unpleasant Surprises Could Be In Store For OPKO Health, Inc.'s (NASDAQ:OPK) Shares (Simply Wall St.)
Jun-02-23 11:31AM	Why Is OPKO Health (OPK) Down 17.2% Since Last Earnings Report? (Zacks)
May-10-23 06:13AM	Gary Nabel Spends US$541k On OPKO Health Stock \ (Simply Wall St.)
May-04-23 12:23PM	OPKO Health (OPK) Q1 Earnings and Revenues Top Estimates (Zacks) +10.46%
05:48AM	Q1 2023 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
May-03-23 10:00PM	Opko Health (OPK) Q1 2023 Earnings Call Transcript (Motley Fool)
06:25PM	OPKO Health (OPK) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:23PM	OPKO Health: Q1 Earnings Snapshot (AP Finance)
04:05PM	OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results (GlobeNewswire)
Apr-25-23 04:05PM	OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023 (GlobeNewswire) -6.16%
Apr-13-23 07:46AM	With 46% ownership, insiders at OPKO Health, Inc. (NASDAQ:OPK) are pretty optimistic and have been buying recently (Simply Wall St.) +5.44%
Mar-17-23 06:21AM	The Chairman & CEO of OPKO Health, Inc. (NASDAQ:OPK), Phillip Frost, Just Bought A Few More Shares (Simply Wall St.)
Mar-14-23 12:08PM	OPKO Health (OPK) to Develop EBV Vaccine With Latest Tie-Up (Zacks) +7.20%
Mar-09-23 03:42PM	10 Penny Stocks with Insider Buying (Insider Monkey) +7.08%
08:00AM	OPKO Health to Hold Virtual R&D Day on March 20, 2023 (GlobeNewswire)
Mar-08-23 04:34PM	Why OPKO Health Shares Jumped on Wednesday (Motley Fool) +6.60%
12:01PM	OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck (Benzinga)
08:05AM	Opko Health shares rise on Merck deal for experimental Epstein-Barr vaccine (Reuters)
08:01AM	Merck, Opko Health sign deal for experimental Epstein-Barr virus vaccine (Reuters)
08:00AM	OPKO Healths ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate (GlobeNewswire)
Feb-26-23 07:13AM	OPKO Health Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
06:40AM	OPKO Health, Inc. (NASDAQ:OPK) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-24-23 10:43AM	OPKO Health (OPK) Q4 Earnings Match Estimates, Revenues Top (Zacks) -5.36%
07:11AM	Q4 2022 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
01:00AM	Opko Health (OPK) Q4 2022 Earnings Call Transcript (Motley Fool)
Feb-23-23 04:05PM	OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results (GlobeNewswire) +5.66%
Feb-16-23 12:17PM	Here's Why You Should Retain OPKO Health (OPK) Stock for Now (Zacks)
11:41AM	OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023 (GlobeNewswire)
Feb-13-23 06:03AM	OPKO Health (NASDAQ:OPK investor five-year losses grow to 68% as the stock sheds US$77m this past week (Simply Wall St.)
Feb-09-23 07:05AM	BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings (PR Newswire)
Jan-14-23 07:26AM	Is There An Opportunity With OPKO Health, Inc.'s (NASDAQ:OPK) 44% Undervaluation? (Simply Wall St.)
Jan-03-23 08:00AM	OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-28-22 10:06AM	3 Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio (Zacks)
Nov-29-22 10:47AM	Here's Why You Should Hold OPKO Health (OPK) Stock For Now (Zacks)
Nov-16-22 05:08AM	Phillip Frost Is The Chairman & CEO of OPKO Health, Inc. (NASDAQ:OPK) And Just Spent US$319k On Shares (Simply Wall St.)
Nov-09-22 08:39AM	OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top (Zacks) -16.22%
Nov-08-22 08:30PM	Opko Health (OPK) Q3 2022 Earnings Call Transcript (Motley Fool)

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FROST PHILLIP MD ET AL	CEO & Chairman	Mar 18 '24	Buy	0.87	500,000	437,100	210,968,225	Mar 18 04:45 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Mar 14 '24	Buy	0.89	500,000	444,300	210,468,225	Mar 14 05:00 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Mar 13 '24	Buy	0.93	500,000	463,750	209,968,225	Mar 13 04:44 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Mar 12 '24	Buy	0.93	600,000	559,380	209,468,225	Mar 12 05:27 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Feb 28 '24	Buy	0.99	500,000	496,150	208,868,225	Feb 28 05:31 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Feb 21 '24	Buy	0.99	1,000,000	991,700	208,368,225	Feb 21 05:10 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Feb 07 '24	Buy	0.98	1,500,000	1,462,800	207,368,225	Feb 07 05:09 PM
KRASNO RICHARD M	Director	Jan 29 '24	Buy	0.99	30,000	29,838	103,333	Jan 29 03:30 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Jan 19 '24	Buy	0.98	500,000	488,650	205,868,225	Jan 19 04:54 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Jan 18 '24	Buy	0.97	400,000	386,200	205,368,225	Jan 18 05:06 PM
HSIAO JANE PH D	Vice Chairman & CTO	Jan 17 '24	Buy	0.95	150,000	142,500	27,999,880	Jan 17 05:09 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Jan 16 '24	Buy	0.95	1,000,000	954,300	204,968,225	Jan 16 05:03 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Jan 11 '24	Buy	0.94	511,531	480,379	203,968,225	Jan 11 05:15 PM
Nabel Gary J.	Chief Innovation Officer	Jan 08 '24	Buy	0.93	216,184	200,427	351,442	Jan 10 05:56 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Jan 05 '24	Buy	0.90	1,500,000	1,344,600	203,456,694	Jan 08 08:54 AM
Zerhouni Elias A.	Vice Chairman and President	Jan 05 '24	Buy	0.93	550,300	514,093	20,327,814	Jan 05 05:26 PM
HSIAO JANE PH D	Vice Chairman & CTO	Jan 05 '24	Buy	0.87	150,010	130,899	27,849,880	Jan 08 09:10 AM
PFENNIGER RICHARD C JR	Director	Jan 05 '24	Buy	0.94	25,000	23,429	325,000	Jan 05 12:42 PM
PAGANELLI JOHN A	Director	Jan 05 '24	Buy	0.88	25,000	22,080	384,340	Jan 05 04:00 PM
Rubin Steven D	Executive VP-Administration	Jan 05 '24	Buy	0.87	10,000	8,669	6,187,732	Jan 05 01:39 PM
PFENNIGER RICHARD C JR	Director	Nov 13 '23	Buy	1.30	25,000	32,491	300,000	Nov 14 07:10 AM
FROST PHILLIP MD ET AL	CEO & Chairman	Nov 10 '23	Buy	1.25	500,000	625,462	201,956,694	Nov 13 08:23 AM
HSIAO JANE PH D	Vice Chairman & CTO	Nov 10 '23	Buy	1.27	100,000	126,659	27,699,870	Nov 13 08:21 AM
Rubin Steven D	Executive VP-Administration	Nov 10 '23	Buy	1.30	10,000	13,000	6,177,732	Nov 13 08:21 AM
FROST PHILLIP MD ET AL	CEO & Chairman	Nov 09 '23	Buy	1.28	500,000	641,471	201,456,694	Nov 13 08:23 AM
FROST PHILLIP MD ET AL	CEO & Chairman	Aug 17 '23	Buy	1.76	100,000	175,804	200,956,694	Aug 18 07:10 AM
FROST PHILLIP MD ET AL	CEO & Chairman	Aug 14 '23	Buy	1.75	75,000	131,260	200,856,694	Aug 15 07:05 AM
FROST PHILLIP MD ET AL	CEO & Chairman	Aug 09 '23	Buy	1.82	100,000	181,752	200,781,694	Aug 10 06:59 AM
FROST PHILLIP MD ET AL	CEO & Chairman	Aug 07 '23	Buy	1.84	650,000	1,194,998	200,681,694	Aug 08 07:07 AM
Nabel Gary J.	Chief Innovation Officer	May 05 '23	Buy	1.84	272,637	500,857	19,912,459	May 08 07:03 AM
Nabel Gary J.	Chief Innovation Officer	May 05 '23	Buy	1.81	187,608	340,042	263,079	May 08 07:03 AM

Open in Screener

VGR

Vector Group Ltd

Apr 24 • 04:00PM ET

10.44

Dollar change -0.01
Percentage change -0.10	%

Consumer Defensive • Tobacco • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI VB IWM VBR VXF IWN DIV VDC IJS

Index	RUT	P/E	8.99	EPS (ttm)	1.16	Insider Own	14.36%	Shs Outstand	154.84M	Perf Week	4.50%
Market Cap	1.65B	Forward P/E	7.85	EPS next Y	1.33	Insider Trans	-0.75%	Shs Float	135.05M	Perf Month	-2.52%
Income	178.53M	PEG	0.47	EPS next Q	0.25	Inst Own	64.45%	Short Float	2.09%	Perf Quarter	-2.61%
Sales	1.42B	P/S	1.16	EPS this Y	0.81%	Inst Trans	-1.75%	Short Ratio	2.70	Perf Half Y	-0.29%
Book/sh	-4.79	P/B	-	EPS next Y	7.26%	ROA	18.68%	Short Interest	2.83M	Perf Year	-17.27%
Cash/sh	2.41	P/C	4.34	EPS next 5Y	19.10%	ROE	-	52W Range	9.80 - 13.43	Perf YTD	-7.45%
Dividend Est.	-	P/FCF	7.89	EPS past 5Y	27.26%	ROI	27.97%	52W High	-22.26%	Beta	1.06
Dividend TTM	0.80 (7.66%)	Quick Ratio	2.88	Sales past 5Y	-3.49%	Gross Margin	32.22%	52W Low	6.53%	ATR (14)	0.22
Dividend Ex-Date	Mar 01, 2024	Current Ratio	3.52	EPS Y/Y TTM	15.86%	Oper. Margin	23.64%	RSI (14)	51.32	Volatility	1.93% 2.00%
Employees	524	Debt/Eq	-	Sales Y/Y TTM	-1.16%	Profit Margin	12.53%	Recom	1.00	Target Price	16.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	21.03%	Payout	68.71%	Rel Volume	0.71	Prev Close	10.45
Sales Surprise	0.77%	EPS Surprise	12.50%	Sales Q/Q	-0.94%	Earnings	Feb 13 AMC	Avg Volume	1.05M	Price	10.44
SMA20	1.22%	SMA50	-2.73%	SMA200	-5.06%	Trades		Volume	747,497	Change	-0.10%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-22	Upgrade	Barclays	Equal Weight → Overweight	$12 → $16
Nov-15-21	Upgrade	Barclays	Underweight → Equal Weight	$13 → $17
Nov-09-21	Upgrade	Oppenheimer	Perform → Outperform	$18
Sep-13-21	Downgrade	Barclays	Equal Weight → Underweight	$15 → $13
Oct-05-20	Initiated	Barclays	Equal Weight	$11
Jul-30-15	Reiterated	Oppenheimer	Outperform	$25 → $27
Jun-05-14	Initiated	Oppenheimer	Outperform	$25
Oct-07-09	Downgrade	Argus	Buy → Hold

Apr-20-24 03:05AM	Want Super-Safe Dividend Income in 2024? Invest in the Following 2 Ultra-High-Yield Stocks. (Motley Fool)
Mar-19-24 06:30AM	Wall Streets Favorite Dividend Stocks? 7 Tickers That Are Practically Money Machines (InvestorPlace)
Feb-28-24 08:21AM	Top 20 Most Valuable Tobacco Companies in the World (Insider Monkey)
Feb-15-24 12:41PM	Vector Group Declares Quarterly Cash Dividend (Business Wire)
08:43AM	Vector Group Ltd. (NYSE:VGR) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:57PM	Loading…
Feb-14-24 11:57PM	Q4 2023 Vector Group Ltd Earnings Call (Thomson Reuters StreetEvents) +15.17%
06:55AM	Vector Group Ltd (VGR) Reports Mixed 2023 Financial Results Amid Market Challenges (GuruFocus.com)
Feb-13-24 04:57PM	Vector: Q4 Earnings Snapshot (Associated Press Finance)
04:30PM	Vector Group Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-07-24 10:00AM	These 2 High-Quality Dividend Stocks Have Towering Yields (Motley Fool)
08:00AM	Vector Group to Host Fourth Quarter and Full Year 2023 Results Conference Call (Business Wire)
Jan-11-24 11:50AM	16 Largest Tobacco Companies in the World by Market Cap (Insider Monkey)
Dec-16-23 09:00PM	Insider Sell Alert: Director Bennett Lebow Sells 171,054 Shares of Vector Group Ltd (VGR) (GuruFocus.com)
Nov-21-23 11:30AM	Vector Group Declares Quarterly Cash Dividend (Business Wire)
Nov-13-23 02:04PM	11 Best Tobacco and Cigarette Stocks To Buy (Insider Monkey)
03:54PM	Loading…
Nov-03-23 03:54PM	Vector Group Ltd. (NYSE:VGR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 09:32PM	Q3 2023 Vector Group Ltd Earnings Call (Thomson Reuters StreetEvents)
08:09AM	Vector Group Ltd (VGR) Reports 7.9% Increase in Q3 Operating Income Despite Revenue Decline (GuruFocus.com)
Nov-01-23 06:04PM	Vector: Q3 Earnings Snapshot (Associated Press Finance)
05:30PM	Vector Group Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-26-23 08:00AM	Vector Group to Host Third Quarter 2023 Results Conference Call (Business Wire)
Oct-09-23 02:45PM	2 Ultra-High-Yield Dividend Stocks to Buy Right Now (Motley Fool)
Sep-18-23 07:17AM	3 Tempting Sin Stocks for the Adventurous Investor (InvestorPlace)
Sep-13-23 09:14PM	Insider Buying: KIRKLAND J BRYANT III Acquires 10,000 Shares of Vector Group Ltd (GuruFocus.com)
Aug-31-23 04:15PM	Vector Group to Present at 2023 Barclays Global Consumer Staples Conference (Business Wire)
Aug-22-23 11:00AM	Vector Group Declares Quarterly Cash Dividend (Business Wire)
Aug-11-23 09:13AM	Calculating The Intrinsic Value Of Vector Group Ltd. (NYSE:VGR) (Simply Wall St.)
Aug-05-23 09:25AM	Vector Group Ltd. (NYSE:VGR) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-04-23 09:26PM	Q2 2023 Vector Group Ltd Earnings Call (Thomson Reuters StreetEvents) -11.46%
Aug-03-23 08:25PM	Vector Group (VGR) Misses Q2 Earnings and Revenue Estimates (Zacks)
07:15PM	Loading…
07:15PM	Vector: Q2 Earnings Snapshot (AP Finance)
05:03PM	Vector Group Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-28-23 08:00AM	Vector Group to Host Second Quarter 2023 Results Conference Call (Business Wire)
Jul-26-23 05:25PM	Carlisle (CSL) Surpasses Q2 Earnings Estimates (Zacks)
Jul-25-23 07:15AM	Danaher (DHR) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-12-23 06:33AM	With 65% institutional ownership, Vector Group Ltd. (NYSE:VGR) is a favorite amongst the big guns (Simply Wall St.)
Jun-30-23 09:54AM	3 Top Stocks From the Buoyant Diversified Operations Industry (Zacks)
Jun-21-23 08:00PM	VGR: Rating decreased to a HOLD (Argus Research)
Jun-15-23 06:09AM	Vector Group's (NYSE:VGR) Dividend Will Be $0.20 (Simply Wall St.)
Jun-13-23 06:37AM	Daily Vickers Top Buyers & Sellers for 06/13/2023 (Argus Research)
Jun-09-23 12:15PM	Vector Group Declares Quarterly Cash Dividend (Business Wire)
Jun-07-23 07:13AM	10 Stocks Wall Street Analysts and Billionaires Are Crazy About (Insider Monkey)
Jun-06-23 07:13AM	Investing in Vector Group (NYSE:VGR) five years ago would have delivered you a 49% gain (Simply Wall St.)
Jun-01-23 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Vector (VGR) (Zacks)
May-29-23 08:00AM	Top Tobacco Stocks for 2023 (Investopedia)
May-16-23 12:45PM	Is Vector (VGR) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
May-10-23 06:11AM	Vector Group First Quarter 2023 Earnings: EPS: US$0.22 (vs US$0.21 in 1Q 2022) (Simply Wall St.)
May-09-23 09:43PM	Q1 2023 Vector Group Ltd Earnings Call (Thomson Reuters StreetEvents) -10.10%
May-08-23 06:55PM	Vector Group (VGR) Q1 Earnings Lag Estimates (Zacks)
05:48PM	Vector: Q1 Earnings Snapshot (AP Finance)
04:24PM	Vector Group Reports First Quarter 2023 Financial Results (Business Wire)
May-02-23 04:15PM	Vector Group to Host First Quarter 2023 Results Conference Call (Business Wire)
Apr-27-23 07:25AM	Honeywell International Inc. (HON) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-26-23 08:00PM	VGR: Lowering target price to $13.00 (Argus Research)
Apr-11-23 09:16AM	Zacks Industry Outlook Highlights General Electric, Vector Group and Live Ventures (Zacks)
Apr-10-23 10:11AM	3 Top Stocks From the Buoyant Diversified Operations Industry (Zacks)
Mar-24-23 06:50AM	Here's Why We Think Vector Group (NYSE:VGR) Is Well Worth Watching (Simply Wall St.)
Mar-15-23 06:44AM	Daily Vickers Top Buyers & Sellers for 03/15/2023 (Argus Research)
Mar-10-23 05:02AM	Vector Group's (NYSE:VGR) Dividend Will Be $0.20 (Simply Wall St.)
Mar-09-23 05:15AM	The Zacks Analyst Blog Highlights TriplePoint Venture Growth BDC, Vector Group, FLEX LNG, Saratoga Investment and Main Street Capital (Zacks)
Mar-08-23 08:16AM	5 Dividend Stocks to Buy as Fed Suggests Further Rate Hikes (Zacks)
Mar-06-23 05:25PM	Vector Group Declares Quarterly Cash Dividend (Business Wire)
Mar-04-23 07:42AM	Estimating The Fair Value Of Vector Group Ltd. (NYSE:VGR) (Simply Wall St.)
Feb-28-23 08:50AM	Here's What Could Help Vector (VGR) Maintain Its Recent Price Strength (Zacks)
Feb-27-23 12:00PM	Vector (VGR) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Feb-18-23 07:04AM	Should You Think About Buying Vector Group Ltd. (NYSE:VGR) Now? (Simply Wall St.)
Feb-15-23 04:10PM	Vector Group Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Feb-10-23 08:45AM	Vector Group to Host Fourth Quarter and Full Year 2022 Results Conference Call (Business Wire)
Feb-05-23 10:40AM	15 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds (Insider Monkey)
Jan-26-23 05:10AM	Got $500? 2 Top Dividend Stocks to Buy in 2023 (Motley Fool)
Jan-07-23 12:34PM	10 Cheap Hot Stocks to Buy Now (Insider Monkey)
Dec-30-22 09:20AM	Vector Group Ltd. (NYSE:VGR) is favoured by institutional owners who hold 58% of the company (Simply Wall St.)
Dec-22-22 06:34AM	Daily Vickers Top Buyers & Sellers for 12/22/2022 (Argus Research)
Dec-03-22 07:35AM	Vector Group Ltd. (NYSE:VGR) Is About To Go Ex-Dividend, And It Pays A 7.0% Yield (Simply Wall St.)
Dec-01-22 08:31AM	Those who invested in Vector Group (NYSE:VGR) five years ago are up 17% (Simply Wall St.)
Nov-28-22 04:25PM	Vector Group Declares Quarterly Cash Dividend (Business Wire)
Nov-01-22 06:45PM	Vector Group (VGR) Misses Q3 Earnings Estimates (Zacks)
04:42PM	Vector Group Reports Third Quarter 2022 Financial Results (Business Wire)
Oct-26-22 08:00AM	Vector Group to Host Third Quarter 2022 Results Conference Call (Business Wire)
Oct-18-22 10:18AM	Can Value Investors Consider Vector Group (VGR) Stock Now? (Zacks)
Oct-04-22 10:30AM	2 Monster Dividend Stocks to Help You Retire Early (Motley Fool)
Sep-27-22 04:26PM	Top Tobacco Stocks for Q4 2022 (Investopedia)
Sep-09-22 08:58AM	Are Options Traders Betting on a Big Move in Vector (VGR) Stock? (Zacks)
Aug-26-22 06:42AM	Vector Group (NYSE:VGR) Is Due To Pay A Dividend Of $0.20 (Simply Wall St.)
Aug-22-22 04:30PM	Vector Group Declares Quarterly Cash Dividend (Business Wire)
Aug-06-22 08:08AM	What Does Vector Group Ltd.'s (NYSE:VGR) Share Price Indicate? (Simply Wall St.)
Aug-04-22 04:45PM	Vector Group Reports Second Quarter 2022 Financial Results (Business Wire)
Jul-29-22 08:45AM	Vector Group to Host Second Quarter 2022 Results Conference Call (Business Wire)
Jul-27-22 09:15AM	Federal Signal (FSS) Q2 Earnings Beat Estimates (Zacks)
Jul-26-22 07:55AM	3M (MMM) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Jul-12-22 08:50AM	Implied Volatility Surging for Vector Group (VGR) Stock Options (Zacks)
Jul-03-22 08:45AM	What You Need To Know About Vector Group Ltd.'s (NYSE:VGR) Investor Composition (Simply Wall St.)
Jun-28-22 11:00AM	2 Top Stocks to Buy if the U.S. Slips Into Recession (Motley Fool)
Jun-20-22 06:15AM	7 Dividend Stocks to Avoid Despite Their Juicy Yields (InvestorPlace)
Jun-17-22 11:23AM	Is Vector Group Stock a Buy? (Motley Fool)
Jun-08-22 08:46AM	Do Options Traders Know Something About Vector Group (VGR) Stock We Don't? (Zacks)
Jun-06-22 03:13PM	Vector Group Declares Quarterly Cash Dividend (Business Wire)
Jun-02-22 12:32PM	Investing in Vector Group (NYSE:VGR) five years ago would have delivered you a 41% gain (Simply Wall St.)
May-10-22 08:55AM	Vector Group (VGR) Lags Q1 Earnings Estimates (Zacks) -13.38%
07:43AM	Vector Group Reports First Quarter 2022 Financial Results (Business Wire)

Vector Group Ltd. is a holding company, which engages in the distribution of tobacco products. It operates through the following segments: Tobacco, Real Estate, and Corporate and Other. The Tobacco segment consists of the manufacturing and sale of cigarettes. The Real Estate segment includes the acquisition and investments in real estate properties and projects. The company was founded in 1980 and is headquartered in Miami, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LEBOW BENNETT S	Director	Dec 14 '23	Sale	11.69	121,054	1,415,605	23,750	Dec 15 05:30 PM
LEBOW BENNETT S	Director	Dec 13 '23	Sale	11.68	50,000	583,945	144,804	Dec 15 05:30 PM
KIRKLAND J BRYANT III	See Remarks	Sep 11 '23	Buy	10.32	10,000	103,200	450,623	Sep 12 08:02 AM
LAMPEN RICHARD	EVP/COO	Sep 08 '23	Buy	10.32	10,000	103,185	797,627	Sep 12 08:44 AM
LEBOW BENNETT S	Director	Jun 09 '23	Sale	12.73	80,000	1,018,616	187,304	Jun 12 08:00 PM
LEBOW BENNETT S	Director	Jun 08 '23	Sale	12.93	80,000	1,034,696	267,304	Jun 12 08:00 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

OPK

Opko Health Inc

VGR

Vector Group Ltd

Upgrade your FINVIZ experience